Index
S&P 500, RUI
Market Cap
63.26B
Enterprise Value
74.79B
Income
3.50B
Sales
21.07B
Book/sh
17.68
Cash/sh
0.46
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
59000
IPO
May 19, 1992
P/E
18.48
Forward P/E
13.98
PEG
4.50
P/S
3.00
P/B
2.47
P/C
94.85
P/FCF
18.99
EV/EBITDA
12.57
EV/Sales
3.55
Quick Ratio
0.81
Current Ratio
1.36
Debt/Eq
0.47
LT Debt/Eq
0.43
Option/Short
Yes / Yes
EPS (ttm)
2.36
EPS next Y
3.12
EPS next Q
0.78
EPS this Y
3.36%
EPS next Y
-1.29%
EPS next 5Y
3.11%
EPS past 3/5Y
63.23% -
Sales past 3/5Y
16.54% 15.16%
EPS Y/Y TTM
25.77%
Sales Y/Y TTM
8.88%
EPS Q/Q
-20.60%
Sales Q/Q
1.44%
Insider Own
0.65%
Insider Trans
2.24%
Inst Own
97.37%
Inst Trans
1.28%
ROA
7.94%
ROE
14.29%
ROIC
9.58%
Gross Margin
65.59%
Oper. Margin
21.44%
Profit Margin
16.62%
SMA20
-1.33%
SMA50
-0.58%
SMA200
-18.65%
Trades
Shs Outstand
1.45B
Shs Float
1.44B
52W High
102.71 -57.50%
52W Low
39.57 10.30%
Volatility
3.25% 3.68%
ATR (14)
1.59
RSI (14)
47.63
Beta
0.57
Rel Volume
0.34
Avg Volume
19.60M
Volume
1,059,375
Perf Week
-2.36%
Perf Month
-3.12%
Perf Quarter
-16.08%
Perf Half Y
-23.17%
Perf YTD
-54.23%
Perf Year
-57.11%
Perf 3Y
-19.68%
Perf 5Y
4.89%
Perf 10Y
101.97%
Prev Close
43.69
Price
43.65
Change %
-0.10%
Analysts 18 incl. previous ratings
Rating Distribution 9 Buy · 9 Hold · 0 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Oct 30, 2026 Downgrade T TD Cowen
Buy → Hold $46 +5.4% Oct 29, 2026 Downgrade O Oppenheimer
Outperform → Perform Oct 28, 2026 Downgrade J JP Morgan
Overweight → Neutral $46 +5.4% Oct 07, 2026 Initiated B Barclays
Equal Weight $48 +10.0% Sep 17, 2026 Downgrade C Citigroup
Buy → Neutral $50 +14.6% Jul 31, 2026 Downgrade A Argus
Buy → Hold May 29, 2026 Downgrade W Wolfe Research
Outperform → Peer Perform May 28, 2026 Downgrade W Wells Fargo
Overweight → Equal Weight $55 +26.0% Mar 30, 2026 Downgrade R Raymond James
Strong Buy → Outperform $88 +101.6% Oct 03, 2025 Downgrade E Erste Group
Buy → Hold Sep 08, 2025 Upgrade O Oppenheimer
Perform → Outperform $125 +186.4% Jun 16, 2025 Initiated L Leerink Partners
Outperform $118 +170.4% Apr 16, 2025 Upgrade N Needham
Hold → Buy $113 +158.9% Jan 10, 2025 Upgrade D Deutsche Bank
Hold → Buy $108 +147.5% Oct 18, 2024 Downgrade N Needham
Buy → Hold May 30, 2024 Initiated G Goldman
Buy $90 +106.2% Feb 01, 2024 Upgrade M Mizuho
Neutral → Buy $65 → $80 +83.3% Jul 19, 2023 Initiated R Robert W. Baird
Outperform $59 +35.2% Jun 30, 2023 Initiated C CL King
Buy $64 +46.6% May 30, 2023 Resumed M Morgan Stanley
Overweight $58 +32.9%
Show Previous Ratings
Nov-13-26 05:20AM
Nov-12-26 04:50PM
10:07AM
Nov-10-26 11:32AM
Nov-06-26 05:28PM
06:04AM
Loading…
Nov-05-26 06:04AM
Nov-04-26 02:47PM
Nov-03-26 07:52AM
05:44AM
Nov-02-26 05:54PM
02:02PM
Oct-29-26 04:05PM
11:41AM
02:41AM
Oct-28-26 04:30PM
02:36PM
Loading…
02:36PM
12:11PM
11:37AM
(The Wall Street Journal)
10:52AM
10:36AM
09:47AM
09:34AM
09:17AM
(Investor's Business Daily)
08:56AM
07:30AM
(The Wall Street Journal)
07:03AM
06:30AM
05:29AM
04:27AM
Oct-26-26 10:24AM
08:00AM
Loading…
08:00AM
Oct-22-26 07:40AM
Oct-15-26 05:01PM
03:18PM
Oct-14-26 04:55PM
Oct-12-26 01:16PM
Oct-09-26 10:32AM
Oct-08-26 06:55AM
Oct-07-26 10:00AM
06:00AM
Oct-06-26 02:00PM
08:18AM
Sep-28-26 03:09PM
Sep-22-26 09:29AM
05:56AM
Sep-17-26 12:31PM
09:47AM
07:59AM
Sep-16-26 06:58AM
Sep-15-26 03:00PM
Sep-14-26 02:16PM
Sep-11-26 02:50PM
07:57AM
Sep-10-26 04:30PM
11:31AM
(The Wall Street Journal)
Sep-09-26 02:06PM
Sep-08-26 04:30PM
01:40PM
01:18PM
11:43AM
(The Wall Street Journal)
10:25AM
09:58AM
(Investor's Business Daily)
07:44AM
07:06AM
06:58AM
(The Wall Street Journal)
06:42AM
05:38AM
Sep-04-26 02:25PM
07:30AM
Sep-03-26 04:17PM
Sep-02-26 01:52PM
Aug-31-26 08:47PM
Aug-28-26 08:05AM
06:15AM
Aug-27-26 12:29PM
06:53AM
Aug-26-26 03:51PM
03:15PM
02:23PM
11:28AM
(The Wall Street Journal)
10:18AM
10:15AM
09:58AM
09:12AM
(Investor's Business Daily)
08:55AM
08:55AM
06:48AM
06:27AM
Aug-25-26 12:05PM
Aug-21-26 02:45PM
Aug-20-26 04:30PM
Aug-13-26 05:21PM
Aug-10-26 02:14PM
08:00AM
Aug-05-26 03:31PM
Jul-31-26 09:46AM
Jul-30-26 04:05PM
Jul-29-26 03:04PM
12:07PM
11:51AM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
O'Sullivan Miriam SVP, Chief HR Officer Nov 01 '26 Option Exercise 0.00 3,871 0 21,437 Nov 03 06:14 PM O'Connor Padraig Andrew EVP, Global Operations Sep 02 '26 Option Exercise 0.00 1,171 0 8,459 Sep 03 04:34 PM Morano Susan E Director Aug 25 '26 Buy 49.22 2,040 100,408 13,784 Aug 26 06:46 PM Habiger David C Director Aug 05 '26 Buy 47.59 2,100 99,937 17,160 Aug 07 04:16 PM Habiger David C Director Aug 03 '26 Buy 48.07 1,042 50,084 14,920 Aug 05 04:15 PM Habiger David C Director Aug 04 '26 Buy 48.59 140 6,802 15,060 Aug 05 04:15 PM Mahoney Michael F Chairman, President & CEO Aug 03 '26 Buy 48.33 186,240 9,001,408 1,590,024 Aug 05 04:15 PM LUDWIG EDWARD J Director Jul 31 '26 Buy 45.48 5,000 227,400 30,359 Aug 03 04:29 PM Monson Jonathan EVP and CFO Jul 01 '26 Option Exercise 0.00 2,087 0 40,073 Jul 02 04:07 PM Pegus Cheryl Director May 20 '26 Buy 56.49 1,770 99,987 1,770 May 21 05:21 PM LUDWIG EDWARD J Director May 20 '26 Buy 56.68 3,580 202,914 25,359 May 21 05:21 PM Habiger David C Director May 20 '26 Buy 55.92 2,250 125,819 13,878 May 21 05:20 PM Habiger David C Director May 19 '26 Buy 56.95 2,200 125,279 11,628 May 21 05:20 PM O'Connor Padraig Andrew EVP, Global Operations May 02 '26 Option Exercise 0.00 1,802 0 7,896 May 04 05:30 PM Butcher Arthur C EVP& Grp Pres, MedSurg & APAC May 02 '26 Option Exercise 0.00 2,102 0 57,894 May 04 05:30 PM Woodworth Emily SVP, Global Controller and CAO Mar 01 '26 Option Exercise 0.00 838 0 3,231 Mar 03 05:19 PM O'Connor Padraig Andrew EVP, Global Operations Feb 16 '26 Option Exercise 0.00 905 0 6,433 Feb 18 05:58 PM O'Connor Padraig Andrew EVP, Global Operations Feb 14 '26 Option Exercise 0.00 1,190 0 5,977 Feb 18 05:58 PM O'Connor Padraig Andrew EVP, Global Operations Feb 13 '26 Option Exercise 0.00 500 0 4,986 Feb 18 05:58 PM Woodworth Emily SVP, Global Controller and CAO Feb 16 '26 Option Exercise 0.00 637 0 2,676 Feb 18 05:58 PM Woodworth Emily SVP, Global Controller and CAO Feb 14 '26 Option Exercise 0.00 661 0 2,335 Feb 18 05:58 PM Woodworth Emily SVP, Global Controller and CAO Feb 13 '26 Option Exercise 0.00 1,413 0 2,364 Feb 18 05:58 PM Monson Jonathan EVP and CFO Feb 16 '26 Option Exercise 0.00 990 0 38,426 Feb 18 05:58 PM Monson Jonathan EVP and CFO Feb 14 '26 Option Exercise 0.00 1,058 0 37,906 Feb 18 05:58 PM Monson Jonathan EVP and CFO Feb 13 '26 Option Exercise 0.00 1,766 0 37,636 Feb 18 05:58 PM O'Sullivan Miriam SVP, Chief HR Officer Feb 16 '26 Option Exercise 0.00 990 0 17,593 Feb 18 05:58 PM O'Sullivan Miriam SVP, Chief HR Officer Feb 14 '26 Option Exercise 0.00 1,124 0 16,932 Feb 18 05:58 PM O'Sullivan Miriam SVP, Chief HR Officer Feb 13 '26 Option Exercise 0.00 588 0 16,008 Feb 18 05:58 PM Mahoney Michael F Chairman, President & CEO Feb 16 '26 Option Exercise 0.00 16,265 0 1,584,725 Feb 18 05:58 PM Mahoney Michael F Chairman, President & CEO Feb 14 '26 Option Exercise 0.00 16,524 0 1,576,450 Feb 18 05:58 PM Mahoney Michael F Chairman, President & CEO Feb 13 '26 Option Exercise 0.00 8,832 0 1,692,025 Feb 18 05:58 PM Fitzgerald Joseph Michael EVP & Group Pres, Cardiology Feb 16 '26 Option Exercise 0.00 3,960 0 215,713 Feb 18 05:58 PM Fitzgerald Joseph Michael EVP & Group Pres, Cardiology Feb 14 '26 Option Exercise 0.00 4,362 0 213,743 Feb 18 05:58 PM Fitzgerald Joseph Michael EVP & Group Pres, Cardiology Feb 13 '26 Option Exercise 0.00 2,797 0 242,485 Feb 18 05:58 PM Butcher Arthur C EVP& Grp Pres, MedSurg & APAC Feb 16 '26 Option Exercise 0.00 2,546 0 57,021 Feb 18 05:57 PM Butcher Arthur C EVP& Grp Pres, MedSurg & APAC Feb 14 '26 Option Exercise 0.00 3,173 0 56,010 Feb 18 05:57 PM Butcher Arthur C EVP& Grp Pres, MedSurg & APAC Feb 13 '26 Option Exercise 0.00 2,237 0 77,987 Feb 18 05:57 PM Brown Vance R EVP, GC and Corp. Secretary Feb 16 '26 Option Exercise 0.00 1,839 0 55,134 Feb 18 05:57 PM Brown Vance R EVP, GC and Corp. Secretary Feb 14 '26 Option Exercise 0.00 1,851 0 54,190 Feb 18 05:57 PM Brown Vance R EVP, GC and Corp. Secretary Feb 13 '26 Option Exercise 0.00 1,118 0 65,131 Feb 18 05:57 PM O'Sullivan Miriam SVP, Chief HR Officer Feb 12 '26 Option Exercise 0.00 961 0 15,758 Feb 17 07:09 PM Woodworth Emily SVP, Global Controller and CAO Feb 12 '26 Option Exercise 0.00 481 0 1,193 Feb 17 07:07 PM O'Connor Padraig Andrew EVP, Global Operations Feb 12 '26 Option Exercise 0.00 1,058 0 4,943 Feb 17 07:07 PM Monson Jonathan EVP and CFO Feb 12 '26 Option Exercise 0.00 1,154 0 36,443 Feb 17 07:06 PM Mahoney Michael F Chairman, President & CEO Feb 12 '26 Option Exercise 0.00 13,704 0 1,425,439 Feb 17 07:06 PM Fitzgerald Joseph Michael EVP & Group Pres, Cardiology Feb 12 '26 Option Exercise 0.00 3,462 0 171,504 Feb 17 07:06 PM Butcher Arthur C EVP& Grp Pres, MedSurg & APAC Feb 12 '26 Option Exercise 0.00 2,692 0 26,292 Feb 17 07:05 PM Brown Vance R EVP, GC and Corp. Secretary Feb 12 '26 Option Exercise 0.00 1,442 0 34,893 Feb 17 07:05 PM Mahoney Michael F Chairman, President & CEO Feb 02 '26 Option Exercise 25.78 95,754 2,468,482 1,572,636 Feb 03 04:12 PM Mahoney Michael F Chairman, President & CEO Feb 02 '26 Sale 93.49 160,901 15,043,394 1,411,735 Feb 03 04:12 PM MICHAEL F MAHONEY Officer Feb 02 '26 Proposed Sale 93.49 160,901 15,043,390 Feb 02 04:12 PM Butcher Arthur C EVP& Grp Pres, MedSurg & APAC Dec 01 '25 Option Exercise 24.81 17,313 429,491 40,913 Dec 02 05:04 PM Butcher Arthur C EVP& Grp Pres, MedSurg & APAC Dec 01 '25 Sale 101.55 17,313 1,758,189 23,600 Dec 02 05:04 PM ARTHUR C BUTCHER Officer Dec 01 '25 Proposed Sale 101.55 17,313 1,758,188 Dec 01 04:02 PM
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
Chairman Mr. Michael F. Mahoney
Executive VP & CFO Mr. Jonathan R. Monson
EVP Mr. Vance R. Brown J.D.
Executive VP & Group President of Cardiovascular Mr. Joseph M. Fitzgerald
Executive VP and Group President of MedSurg & Asia Pacific Mr. Arthur Crosswell Butcher